Abstract In the Asia-Pacific region, Mycoplasma pneumoniae (MP) could be a notable
pathogen responsible for adult community-acquired pneumonia (CAP), with varying …

Background Drug resistant Mycoplasma pneumoniae (MP) is a rising issue in the
management of community-acquired pneumonia (CAP). Epidemiological monitoring is …

Objectives To determine the prevalence of resistance to macrolides in Mycoplasma
pneumoniae worldwide. Methods Prior to 12 December 2020, PubMed, Web of Science …

Introduction Mycoplasma pneumoniae (M. pneumoniae) is the major pathogen involved in
community-acquired pneumonia in all age groups. Resistance to macrolides, the first-line …

Macrolide-resistant Mycoplasma pneumoniae (MRMP) is rapidly emerging in Asia, but
information on the temporal relationship between the increase in macrolide resistance and …

Pneumonia caused by Mycoplasma pneumoniae (M. pneumoniae pneumonia) is a major
cause of community-acquired pneumonia worldwide. The surveillance of M. pneumoniae …

This paper retrospectively analysed the prevalence of macrolide-resistant Mycoplasma
pneumoniae (MRMP) in some parts of China. Between January 2013 and December 2019 …

Mycoplasma pneumoniae is a major pathogen causing community-acquired pneumoniae
(CAP), which is generally treated with macrolides. In recent years, however, although …

Aims: Although the cases of macrolide-resistant Mycoplasma pneumoniae (MRMP) have
been increasing substantially among children, there are very few studies that have focused …

Abstract Objective Mycoplasma pneumoniae (Mp) is one of the major pathogens that causes
respiratory tract infections, and macrolide resistance has increased rapidly in recent years …